Novavax, Inc.

Home » Novavax, Inc.

Secondary

Novavax, Inc.

Novavax is a clinical-stage biotechnology company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.

Symbol

NVAX

Last Closing Price
$1.65

Shares
30,000,000

Anticipated Date
TBD

Underwriters
Citigroup, Piper Jaffray

To view the prospectus for Novavax, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253